SCRI-Tennessee Oncology — Nashville, Tennessee

SCRI-Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI-Tennessee Oncology has participated in 6 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer, Solid Tumors, Lymphocytic Leukemia, Chronic.

Sponsors: Genentech, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI-Tennessee Oncology?

SCRI-Tennessee Oncology has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI-Tennessee Oncology conducted?

SCRI-Tennessee Oncology has 6 clinical trials on record. Their work covers Non-Small Cell Lung Cancer, Solid Tumors, Lymphocytic Leukemia, Chronic.

Is SCRI-Tennessee Oncology accredited by Crixeo Health?

SCRI-Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI-Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.